This video examines the results of a retrospective study that compared chemotherapy alone or with prophylactic cranial irradiation in extensive-stage SCLC patients with no brain metastases.
The role of prophylactic cranial irradiation (PCI) in patients with extensive-stage small-cell lung cancer (SCLC) remains controversial, with previous studies reporting conflicting results.
In this video, Sonam Sharma, MD, of the University of Pennsylvania, Philadelphia, discusses results of a National Cancer Database study that looked at metastatic SCLC patients without brain metastases who received either chemotherapy (n = 3,784) or chemotherapy plus PCI (n = 473).
Sharma presented the results of the study (abstract 11) at the 2017 Multidisciplinary Thoracic Cancers Symposium, held March 16–18 in San Francisco.
Eric Ko on Combining Radiation Therapy With Immunotherapy to Treat Non–Small-Cell Lung Cancer
September 18th 2018ONCOLOGY spoke with Eric Ko, MD, PhD, who recently published a review article with his colleagues on strategies for combining radiation therapy with immunotherapy for the treatment of non–small-cell lung cancer.